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Gastrointestinal manifestations of COVID-19 are rare and have primarily been limited to diarrhea or vomiting.
Intussusception is the most common cause of bowel obstruction in infants, with up to 30% of pediatric intus
susception cases having a preceding viral illness. We present the rare case of intussusception in a SARS-CoV-2
positive infant. This is the first documented case of survival in a SARS-CoV-2 positive patient presenting with
intussusception as the primary manifestation. As our knowledge of this disease evolves, surgeons need to remain
suspicious for possible gastrointestinal manifestations of COVID-19.

1. Introduction
The COVID-19 pandemic has brought the world to a standstill,
causing the loss of countless lives and wreaking financial havoc. It was
first reported as a cluster of patients with severe pneumonia symptoms,
linked to a seafood market in Wuhan, China. Caused by the Severe Acute
Respiratory Syndrome Coronavirus 2 (SARS-CoV-2), it has spread to, as
of 29th May 2020, 215 countries or territories and has resulted in 5.7
million infected and over 350,000 deaths [1]. Symptoms range widely
from mild, including fever, dry cough, dyspnea, myalgia, vomiting and
diarrhea, to potentially fatal respiratory distress Respiratory symptoms
are the most common.
Children tend to be less likely to be COVID-19 positive and are
usually afflicted with milder symptoms [2]. Among 44,762 laboratory
confirmed cases from China, only 416 (1%) and 549 (1%) were from age
groups <10 and 10–19 years [3]. Similar statistics have emerged from
the USA. Out of 22,060 COVID-19 related hospitalizations between
March 1st and March 16th, 2020, only 68 (0.003%) and 91 (0.004%) fell
in the 0–4 and 5–17 years age groups. The cumulative rate per 100,000
was thus 3.5 and 1.7 in 0–4 and 5-17 year-olds [4]. Furthermore,
presence of symptoms was less frequent in children compared to adults,
along with a shorter course of illness, as suggested by the fact that the
median duration of fever was 3 days in children, compared to 10 days in
adults [5]. Children with severe symptoms usually tend to have under
lying medical conditions or comorbidities, with some children exhibit
ing an insidious onset of respiratory symptoms, only being revealed after
CT scans were conducted. A case series from the UK documented 8

COVID-19 patients presenting with fever, abdominal pain and diarrhea
with a working diagnosis of systemic sepsis secondary to suspected
appendicitis [6]. This highlights the possible gastrointestinal compli
cations that are possible with SARS-CoV-2 infection. Another case series
of 5 pediatric patients presenting with non-respiratory symptoms was
conducted in Wuhan, China. Of note, Case 1 in that series was of a
10-month-old female with intussusception who tested positive for
SARS-CoV-2 [7].
Intussusception is the most common cause of bowel obstruction in
infants, most commonly occurring between the ages of 4 and 10 months
[8]. Viral illnesses are known to cause intussusception. Its incidence
ranges between 0.24 and 2.4 per 1000 live births, while the mortality
rate is 2.1 per 1 million live births in the US. However, case fatality rates
are much higher in Africa (9.4%) [9].
We present the unusual case of a patient with intussusception who
was subsequently diagnosed to be SARS-CoV-2 positive.
2. Case presentation
A 4 months, 25 days old baby boy presented to the emergency room
at Aga Khan University Hospital (AKUH), Karachi, Pakistan, with a twoday history of acute onset, intermittent, severe, crampy abdominal pain,
accompanied by inconsolable crying and drawing up of the legs towards
the abdomen and reluctance to feed. Each episode occurred at an in
terval of 20–30 minutes and lasted for 15–20 minutes. With the passage
of time, the episodes became more prolonged and severe. He had
developed 2 episodes of per rectal bleeding in the preceding 24 hours
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which was fresh but also mixed with mucoid stool (currant jelly). He was
taken to a family physician and then spent 12 hours at a government
hospital being treated for gastroenteritis. There was no fever, vomiting,
or diarrhea.
The child was otherwise healthy, vaccinated according to the
Extended Program for Immunization (EPI) protocol, and had no signif
icant past surgical history. However, he had recovered from an upper
respiratory tract infection (URTI) with symptoms of fever, cough and
rhinorrhea 1 week prior to the development of his current gastrointes
tinal symptoms, for which he was seen in a polyclinic by a family
physician and prescribed antipyretics and supportive management.
On physical examination in the emergency room, he appeared to be a
pale, irritable child. His heart rate was 136 beats per minute, he was
afebrile, with an oxygen saturation of 98% and a sausage shaped lump
palpable in the right upper abdomen. The rest of his systemic exami
nation including the respiratory system and ENT was unremarkable.

Table 1
Comparison of our patient with the patient reported by Cai et al.
Underlying
disease
Gender
Age
Exposure history
First clinical
manifestation

Fever
Days from onset of
symptoms to
admission
Complications

2.1. Investigations

Treatment
Surgical
Medical

The child was found to have hypochromic microcytic anemia (Hb:
9.2 g/dL) along with a total leucocyte count of 9.9 � 109/L (raised
monocytes 12.1%). Ultrasound abdomen confirmed intussusception
(Fig. 1).
2.2. Management
The patient was resuscitated in the emergency room. Broad spectrum
intravenous antibiotics were administered (listed in Table 1) and
pneumatic reduction of intussuscepted bowel (ileocolic intussusception)
was performed under fluoroscopic guidance in the radiology suite after
insufflation of air at 100 mm Hg for 3 minutes under two attempts. Free
flow of air was observed in the large and small bowel, representing a
successful reduction of intussusception. No immediate post procedure
complication was noted.
The patient was then admitted for further observation. Due to the
ongoing pandemic and positive history of URTI one week prior, he was
screened for SARS-CoV-2 (COVID-19) using a nasal swab (qualitative
PCR) which was positive (Report as per CAP guidelines on 23rd March
2020). The child had no Covid-19 contact history.
He then underwent a chest x-ray (Fig. 2) which was normal, and his
blood work included:

Length of stay
(days)
Outcome

Moazzam et al.

Cai et al.

Intussusception

Intussusception

Male
4 months, 25 days
None
Acute, intermittent, crampy
abdominal pain,
inconsolable crying, per
rectal bleeding (currant
jelly stool)
Afebrile

Female
10 months
None
Paroxysmal crying, vomiting,
currant jelly-like stool

2

Febrile (Maximum
temperature ¼ 39.8 � C)
1.25

None

Shock; MODS (liver, kidney,
myocardium, DIC, acute
respiratory failure

Pneumatic Reduction
� IV Co-Amoxiclav 30mg/
kg Q8H for 3 days
� Amikacin 15 mg/kg QD
for 3 days
� Metronidazole 10 mg/kg
Q8H for 3 days
� Paracetamol 15 mg/kg
Q6H
*Patient did not receive
treatment for any other
COVID-19 complications
2.5

Pneumatic Reduction
� Intravenous ribavirin
� Aerosol inhalation of
interferon
� Methylprednisolone - 2 mg/
(kg⋅d) for 5 days
� Intravenous
immunoglobulin - 500 mg/
(kg⋅d) for 3 days

In good health one-week
post-discharge

Death

36

The patient’s recovery was uneventful, and his diet was established in 24
hours. He was discharged in a stable condition after a total hospital stay
of 60 hours. Throughout the hospital course, he did not develop any
respiratory symptoms or signs of sepsis and was recovering and in good
health 1-week post-discharge.
3. Discussion
According to our literature review, this is only the second such
instance of a SARS-CoV-2 positive patient presenting to a healthcare
center with intussusception as the primary manifestation, and the first
documented case in which the patient survived. The only other docu
mented case was in Wuhan, China. In that particular case, the patient
was a 10-month-old female who presented with fever, restlessness,
vomiting and currant jelly-like stool for 30 hours. However, there were

� CRP:3.7 (0–10 mg/dL),
� Ferritin:162.9 (22–322 ng/mL),
� D-Dimer:3.8 (<0.5 mg/L FEU).
The patient did not receive any treatment for COVID-19 as he was
asymptomatic, however, the parents were advised to follow isolation
protocols and return immediately upon the development of symptoms.

Fig. 1. There is evidence of telescoping of bowel within the bowel loop in right upper quadrant of abdomen in the subhepatic region giving doughnut sign. Ap
pearances are suggestive of intussusception.
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can cause intussusception [19]. A study from 1990 showed that rota
virus had a seasonal peak temperate climates while being present
throughout the year in the tropics [20]. However, a subsequent
large-scale review demonstrated that country income level was more
predictive of the likelihood of having seasonal disease [21]. Poliovirus,
enterovirus, parechovirus and norovirus have also been found in the
stool specimens of affected patients [22]. After the viral illness, children
tend to present with acute onset colicky abdominal pain, excessive ir
ritability, vomiting and a “currant jelly” stool due to the presence of
blood and mucus. This course is intermittent, in that the child may re
turn to a normal level of activity in between bouts of symptoms.
Our case also followed a similar pattern, with a viral URTI illness
preceding the onset of intussusceptive symptoms. This raises suspicion
of SARS-CoV-2 directly affecting the gastrointestinal tract, leading to
mesenteric adenitis and resulting in intussusception. This would be the
first such reported incidence of intussusception as a manifestation of
SARS-CoV-2 infection, with no respiratory symptoms. It is plausible that
the respiratory symptoms that the child had one week prior were in fact
due to SARS-CoV-2 and the intussusception episode was a delayed
complication instead of a primary manifestation. Another explanation
for this could be that the child had contracted an upper respiratory tract
infection (URTI) of undocumented etiology and thus developed intus
susception, subsequently contracting SARS-CoV-2 during the course of
his visit to the government hospital whilst seeking treatment for his
URTI. Furthermore, contracting SARS-CoV-2 during his stay at our
hospital is highly unlikely, given that he was tested only 13 hours after
admission and the child did not develop any respiratory symptoms
during his hospital stay or in the week after discharge.
Testing rates in the pediatric population are much lower compared to
adults and elderly globally. The WHO, CDC and numerous government
health agencies emphasize fever and respiratory symptoms in the testing
criteria for suspected cases [23]. Since both of these are present in less
than 50% of pediatric cases [10], it raises substantial concern for un
derestimation of pediatric cases of COVID-19. As a result, testing rates
globally must be enhanced to gauge the true disease burden and to gain
a better understanding of the associated complications.

Fig. 2. Chest radiograph AP supine projection; No evidence of any active
cardiac or pulmonary disease noted.

no respiratory symptoms or exposure to COVID-19. After successful
diagnostic air enema, the child developed a high fever, became drowsy
and developed intermittent convulsions. Signs of multiorgan failure
(liver, kidney and myocardium), along with disseminated intravascular
coagulation also developed. The patient subsequently tested positive for
SARS-CoV-2 twice in throat swab samples. Furthermore, necrosis of the
proximal ileum was discovered with subsequent resection. On day 36,
the patient died due to multiorgan failure [7]. A comparison of the two
documented SARS-CoV-2 positive patients who developed intussuscep
tion has been detailed in Table 1.
Although gastrointestinal symptoms have been documented in
COVID-19, they are rare and have primarily been limited to diarrhea or
vomiting. A review of 452 patients in 23 studies revealed that diarrhea
(6.6%) and vomiting (5.8%) were far less than common than fever
(43.1%) or cough (43.4%) [10]. Overall, symptoms in the pediatric
population were shown to be milder in the pediatric population in a case
series of 2135 patients in China. When the symptoms were classified as
asymptomatic, mild, moderate, severe or critical, the distribution was
4.4%, 51.0%, 38.7%, 5.3% and 0.6% respectively. However, in children
less than 1 year of age, the proportion of patients with severe or critical
illness was markedly higher at 8.8% and 1.9%. As a result, it concluded
that although children generally developed milder symptoms, infants in
particular were vulnerable to severe or critical illness [11–13].
Furthermore, infants had higher hospitalization rates (15%–62%)
compared to older children (1–17 years) (4.1%–14%) and adults. Mul
tiple mechanisms for the milder symptoms have been proposed. The
SARS-CoV-2 virus downregulates ACE2 expression thus impairing
angiotensin-2 metabolism, which promotes lung injury. High levels of
ACE-2 are present in children, thus they may be protective against se
vere illness [5,14,15]. Furthermore, it has been proposed that countries
with routine BCG vaccination have lower COVID-19 mortality and
morbidity rates [16]. As aging occurs, the regenerative capacity of lungs
gradually decreases, thus the lungs in children are better placed to
recover from COVID-19 [17]. Conversely, an inadequate adaptive im
munity response due to an immature immune system could account for
the poorer prognosis in infants compared to young children.
Viral shedding in COVID-19 patients primarily occurs through nasal
secretions, however, a feco-oral route of transmission has also been
postulated. This is supported by a study which found that 8 out of 10
COVID-19 positive children had positive rectal swabs, even after their
nasopharyngeal swabs had turned negative [18].
Intussusception may be caused by anatomical causes, associated
diseases and pertinent to this case, viral infections. However, only 10%
of patients have an identifiable cause of the intussusception, with the
vast majority being idiopathic. Infections can cause mesenteric lymph
adenopathy and hypertrophy of Peyer patches, which can act as a lead
point for the intussusceptum. Approximately 30% of pediatric intus
susception cases have a preceding viral illness. Adenovirus and Rota
virus, along with some parasites, have been identified as agents which

4. Conclusion
We report, to the best of our knowledge, the first documented
instance of survival in a case of intussusception in a SARS-CoV-2 positive
pediatric patient. Owing to the dearth of literature on this subject,
further studies need to be conducted on the gastrointestinal complica
tions associated with COVID-19. Since the knowledge of this virus is still
evolving, surgeons need to remain suspicious for possible gastrointes
tinal manifestations of SARS-CoV-2.
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